Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

Mutasem Elfalah,1 Saif Aldeen AlRyalat,1 Mario Damiano Toro,2– 4 Robert Rejdak,4 Sandrine Zweifel,3 Rashed Nazzal,5 Mohammed Abu-Ameerh,1 Osama Ababneh,1 Almutez Gharaibeh,1 Zuhair Sharif,1 Jehad Meqbil,1 Mo’ath AlShawabkeh,1 Amal Alwreikat,6 Muawyah Al Bdour,1 Maysa Al-Hussaini,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elfalah M, AlRyalat SA, Toro MD, Rejdak R, Zweifel S, Nazzal R, Abu-Ameerh M, Ababneh O, Gharaibeh A, Sharif Z, Meqbil J, AlShawabkeh M, Alwreikat A, Al Bdour M, Al-Hussaini M, Yousef YA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/eb71403e322748f48ca820fb0ccb3f36
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb71403e322748f48ca820fb0ccb3f36
record_format dspace
spelling oai:doaj.org-article:eb71403e322748f48ca820fb0ccb3f362021-12-02T14:12:25ZDelayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor1177-5483https://doaj.org/article/eb71403e322748f48ca820fb0ccb3f362021-02-01T00:00:00Zhttps://www.dovepress.com/delayed-intravitreal-anti-vegf-therapy-for-patients-during-the-covid-1-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Mutasem Elfalah,1 Saif Aldeen AlRyalat,1 Mario Damiano Toro,2– 4 Robert Rejdak,4 Sandrine Zweifel,3 Rashed Nazzal,5 Mohammed Abu-Ameerh,1 Osama Ababneh,1 Almutez Gharaibeh,1 Zuhair Sharif,1 Jehad Meqbil,1 Mo’ath AlShawabkeh,1 Amal Alwreikat,6 Muawyah Al Bdour,1 Maysa Al-Hussaini,7 Yacoub A Yousef8 1Department of Special Surgery, Faculty of Medicine, The University of Jordan, Amman, Jordan; 2Faculty of Medical Sciences, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland; 3Department of Ophthalmology, University Hospital of Zürich, Zürich, Switzerland; 4Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland; 5Shami Eye Center, Amman, Jordan; 6Department of Ophthalmology, Royal Medical Services, Amman, Jordan; 7Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan; 8Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman, JordanCorrespondence: Mutasem ElfalahDepartment of Special Surgery, Faculty of Medicine, The University of Jordan, Queen Rania St, Amman, 11941, JordanTel +96265355000Email mutasemrabie@hotmail.comMario Damiano ToroDepartment of Ophthalmology, University Hospital of Zürich, Raemistrasse 100, Zürich, 8091, SwitzerlandTel +39 3495158220Email toro.mario@email.itPurpose: To assess the impact of Jordanian’s Corona Virus Disease (COVID-19) lockdown on visual acuity and macular thickness in patients with macular edema receiving intravitreal injections, and to assess the ethical endeavor of lockdown among serious sight threatening conditions.Patients and Methods: This retrospective observational study included patients planned for intravitreal injections who did not complete the planned course before the lockdown (ie, before 20th of March 2020). Data included demographics, indication for the intravitreal injection, corrected distance visual acuity (CDVA), and central macular thickness on Optical Coherence Tomography (OCT) before and after the lockdown.Results: One-hundred and sixty-six eyes of 125 patients were studied, 68 (54.4%) patients were males, and the mean (± standard deviation, SD) age was 64.79 (± 9.41) years. Mean (±SD) duration of delay in the planned injection was 60.97 (± 24.35) days. The change in visual acuity was statistically significant for patients with diabetic macular edema (p= 0.045 improvement), patients with central retinal vein thrombosis (CRVO) (p= 0.05 deterioration), and patients with age-related macular degeneration (AMD) (p= 0.005 deterioration). Of interest, delay of more than 2 months and the previous need for 3 or more injections were significant poor prognostic factors for visual outcome for patients with diabetic macular edema (p=0.027 and 0.045).Conclusion: The impact of delay in the scheduled intravitreal injections resulted in variable outcomes depending on the indication. Triaging the urgency of patients should be based on the indication to support the equity principle of bioethics, where those in need are prioritized against others, depending on potential adverse outcome.Keywords: COVID-19 lockdown, COVID-19 pandemic, ethics, intravitreal injection, macular edemaElfalah MAlRyalat SAToro MDRejdak RZweifel SNazzal RAbu-Ameerh MAbabneh OGharaibeh ASharif ZMeqbil JAlShawabkeh MAlwreikat AAl Bdour MAl-Hussaini MYousef YADove Medical Pressarticlecovid-19 lockdowncovid-19 pandemicethicsintravitreal injectionmacular edema.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 661-669 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19 lockdown
covid-19 pandemic
ethics
intravitreal injection
macular edema.
Ophthalmology
RE1-994
spellingShingle covid-19 lockdown
covid-19 pandemic
ethics
intravitreal injection
macular edema.
Ophthalmology
RE1-994
Elfalah M
AlRyalat SA
Toro MD
Rejdak R
Zweifel S
Nazzal R
Abu-Ameerh M
Ababneh O
Gharaibeh A
Sharif Z
Meqbil J
AlShawabkeh M
Alwreikat A
Al Bdour M
Al-Hussaini M
Yousef YA
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
description Mutasem Elfalah,1 Saif Aldeen AlRyalat,1 Mario Damiano Toro,2– 4 Robert Rejdak,4 Sandrine Zweifel,3 Rashed Nazzal,5 Mohammed Abu-Ameerh,1 Osama Ababneh,1 Almutez Gharaibeh,1 Zuhair Sharif,1 Jehad Meqbil,1 Mo’ath AlShawabkeh,1 Amal Alwreikat,6 Muawyah Al Bdour,1 Maysa Al-Hussaini,7 Yacoub A Yousef8 1Department of Special Surgery, Faculty of Medicine, The University of Jordan, Amman, Jordan; 2Faculty of Medical Sciences, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland; 3Department of Ophthalmology, University Hospital of Zürich, Zürich, Switzerland; 4Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland; 5Shami Eye Center, Amman, Jordan; 6Department of Ophthalmology, Royal Medical Services, Amman, Jordan; 7Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan; 8Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman, JordanCorrespondence: Mutasem ElfalahDepartment of Special Surgery, Faculty of Medicine, The University of Jordan, Queen Rania St, Amman, 11941, JordanTel +96265355000Email mutasemrabie@hotmail.comMario Damiano ToroDepartment of Ophthalmology, University Hospital of Zürich, Raemistrasse 100, Zürich, 8091, SwitzerlandTel +39 3495158220Email toro.mario@email.itPurpose: To assess the impact of Jordanian’s Corona Virus Disease (COVID-19) lockdown on visual acuity and macular thickness in patients with macular edema receiving intravitreal injections, and to assess the ethical endeavor of lockdown among serious sight threatening conditions.Patients and Methods: This retrospective observational study included patients planned for intravitreal injections who did not complete the planned course before the lockdown (ie, before 20th of March 2020). Data included demographics, indication for the intravitreal injection, corrected distance visual acuity (CDVA), and central macular thickness on Optical Coherence Tomography (OCT) before and after the lockdown.Results: One-hundred and sixty-six eyes of 125 patients were studied, 68 (54.4%) patients were males, and the mean (± standard deviation, SD) age was 64.79 (± 9.41) years. Mean (±SD) duration of delay in the planned injection was 60.97 (± 24.35) days. The change in visual acuity was statistically significant for patients with diabetic macular edema (p= 0.045 improvement), patients with central retinal vein thrombosis (CRVO) (p= 0.05 deterioration), and patients with age-related macular degeneration (AMD) (p= 0.005 deterioration). Of interest, delay of more than 2 months and the previous need for 3 or more injections were significant poor prognostic factors for visual outcome for patients with diabetic macular edema (p=0.027 and 0.045).Conclusion: The impact of delay in the scheduled intravitreal injections resulted in variable outcomes depending on the indication. Triaging the urgency of patients should be based on the indication to support the equity principle of bioethics, where those in need are prioritized against others, depending on potential adverse outcome.Keywords: COVID-19 lockdown, COVID-19 pandemic, ethics, intravitreal injection, macular edema
format article
author Elfalah M
AlRyalat SA
Toro MD
Rejdak R
Zweifel S
Nazzal R
Abu-Ameerh M
Ababneh O
Gharaibeh A
Sharif Z
Meqbil J
AlShawabkeh M
Alwreikat A
Al Bdour M
Al-Hussaini M
Yousef YA
author_facet Elfalah M
AlRyalat SA
Toro MD
Rejdak R
Zweifel S
Nazzal R
Abu-Ameerh M
Ababneh O
Gharaibeh A
Sharif Z
Meqbil J
AlShawabkeh M
Alwreikat A
Al Bdour M
Al-Hussaini M
Yousef YA
author_sort Elfalah M
title Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
title_short Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
title_full Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
title_fullStr Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
title_full_unstemmed Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
title_sort delayed intravitreal anti-vegf therapy for patients during the covid-19 lockdown: an ethical endeavor
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/eb71403e322748f48ca820fb0ccb3f36
work_keys_str_mv AT elfalahm delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT alryalatsa delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT toromd delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT rejdakr delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT zweifels delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT nazzalr delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT abuameerhm delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT ababneho delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT gharaibeha delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT sharifz delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT meqbilj delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT alshawabkehm delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT alwreikata delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT albdourm delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT alhussainim delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
AT yousefya delayedintravitrealantivegftherapyforpatientsduringthecovid19lockdownanethicalendeavor
_version_ 1718391819760304128